Data suggests new Covid 19 strain brings increased risk of reinfection.
Pfizer and BioNTech are among the vaccine manufacturers insisting they'll be able adapt their products if the Omicron variant continues to spread.
Data suggests the new Covid 19 strain - first identified in South Africa - brings an increased risk of reinfection.
The World Health Organistation's calling it a "variant of concern".
But Jonathan Ball - a professor of molecular virology - says we shouldn't get ourselves into a "frenzy".

Man Dies Following Assault In Blanchardstown On Sunday
Value Of Unused Medication Each Year Estimated At Over €37.5M
Appeal Against Country's First Ever Supervised Injection Centre Rejected
Woman Caught On Laptop While Driving As National Day Of Action For Mobile Phone Distraction Takes Place
RTÉ Senior Management Due Before Oireachtas Committee Today
Man Dies After Road Collision In Carlow
Rent Prices Now 40% Above Pre-Covid Levels
Meta Employees To Find Out Today If They'll Be Affected By Job Losses